10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2015

Filing Information

Form Type	10-K
Accession Number	`0001144204-16-110594`
Period End Date	20160331
Filing Date	20160629
Fiscal Year	2015
Fiscal Period	FY
XBRL Instance	ameh-20160331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 36 Cash Flow Statement 124 Stockholders Equity 27

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$165.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$601.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $601,000 and $165,000 at March 31, 2016 and 2015, respectively	`AccountsReceivableNetCurrent`	$3.39M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $601,000 and $165,000 at March 31, 2016 and 2015, respectively	`AccountsReceivableNetCurrent`	$3.80M	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$208.29K	USD	Point-in-time
Other receivables	`AccountsAndOtherReceivablesNetCurrent`	$581.21K	USD	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$36.40K	USD	Point-in-time
Due from Affiliates	`DueFromAffiliateCurrent`	$20.50K	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$293.83K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$792.57K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$13.56M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$9.85M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$264.71K	USD	Point-in-time
Deferred financing costs, net	`DeferredFinanceCostsNoncurrentNet`	$37.93K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.88M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	4.86M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.88M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	4.86M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.25M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$582.47K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndInvestmentsCurrent`	$530.00K	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$2.35M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$1.38M	USD	Point-in-time
Goodwill	`Goodwill`	$1.62M	USD	Point-in-time
Goodwill	`Goodwill`	$2.17M	USD	Point-in-time
Goodwill	`Goodwill`	$494.70K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$216.44K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$218.72K	USD	Point-in-time
Total assets	`Assets`	$15.00M	USD	Point-in-time
Total assets	`Assets`	$19.57M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.57M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.34M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$1.26M	USD	Point-in-time
Medical liabilities	`MedicalLiabilitiesCurrent`	$2.67M	USD	Point-in-time
Notes and lines of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$188.76K	USD	Point-in-time
Notes and lines of credit payable, net of discount, current portion	`NotesAndLinesOfCreditPayableCurrent`	$327.14K	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	$1.04M	USD	Point-in-time
Convertible notes payable, net of discount, current portion	`ConvertibleNotesPayableCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.97M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.43M	USD	Point-in-time
Notes, net of discount, non-current portion	`LongTermNotesPayable`	$6.23M	USD	Point-in-time
Notes, net of discount, non-current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount, non-current portion	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes payable, net of discount, non-current portion	`ConvertibleLongTermNotesPayable`	$1.46M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.81M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.14M	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$728.88K	USD	Point-in-time
Deferred rent liability	`DeferredRentCreditNoncurrent`	$11.61K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$43.48K	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilities`	$171.22K	USD	Point-in-time
Total liabilities	`Liabilities`	$15.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$11.02M	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS, CONTINGENCIES AND SUBSEQUENT EVENTS	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 5,876,852 and 4,863,389 shares issued and outstanding at March 31, 2016 and 2015, respectively	`CommonStockValue`	$4.86K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 5,876,852 and 4,863,389 shares issued and outstanding at March 31, 2016 and 2015, respectively	`CommonStockValue`	$5.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$23.52M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$16.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-19.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.68M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-1.27M	USD	Point-in-time
Stockholders' deficit attributable to Apollo Medical Holdings, Inc.	`StockholdersEquity`	$-2.82M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$1.83M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.74M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.47M	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$15.00M	USD	Point-in-time
TOTAL LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS EQUITY (DEFICIT)	`LiabilitiesAndStockholdersEquity`	$19.57M	USD	Point-in-time

Income Statement 36 line items

Line Item	Tag	Value	Unit	Period
Net revenues	`Revenues`	$44.05M	USD	Annual
Net revenues	`Revenues`	$32.99M	USD	Annual
Cost of services	`CostOfServices`	$34.00M	USD	Annual
Cost of services	`CostOfServices`	$22.07M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$11.28M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$16.96M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$334.43K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$351.40K	USD	Annual
Total costs and expenses	`OperatingExpenses`	$33.68M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$51.31M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-7.27M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-694.33K	USD	Annual
Interest expense	`InterestExpense`	$542.30K	USD	Annual
Interest expense	`InterestExpense`	$1.33M	USD	Annual
(Loss) gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$-408.69K	USD	Annual
(Loss) gain on change in fair value of warrant and conversion feature liabilities, net	`GainLossOnDerivativeInstrumentsNetPretax`	$833.54K	USD	Annual
Loss on debt extinguishment, net	`ExtinguishmentOfDebtGainLossNetOfTax`	-	USD	Annual
Loss on debt extinguishment, net	`ExtinguishmentOfDebtGainLossNetOfTax`	$-266.37K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$3.03K	USD	Annual
Other income	`OtherNonoperatingIncomeExpense`	$239.06K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-489.83K	USD	Annual
Total other expense, net	`NonoperatingIncomeExpense`	$-978.30K	USD	Annual
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.24M	USD	Annual
Loss before (benefit) provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-1.18M	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$163.79K	USD	Annual
(Benefit) provision for income taxes	`IncomeTaxExpenseBenefit`	$-71.04K	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-8.17M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.17M	USD	Annual
Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$454.64K	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-9.34M	USD	Annual
Net loss attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$-1.80M	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.79	USD	Annual
Basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.37	USD	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.89M	shares	Annual
Basic and diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.21M	shares	Annual

Cash Flow Statement 124 line items

Line Item	Tag	Value	Unit	Period
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	$660.89K	USD	Annual
Acquisitions, net of cash acquired	`CashAcquiredFromAcquisition`	-	USD	Annual
Net loss	`ProfitLoss`	$-1.35M	USD	Annual
Net loss	`ProfitLoss`	$-8.17M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$435.84K	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$64.81K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$334.43K	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$351.40K	USD	Annual
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	-	USD	Annual
Gain on sale of marketable securities	`MarketableSecuritiesGainLoss`	$49.79K	USD	Annual
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	-	USD	Annual
Loss on disposal of assets	`GainLossOnDispositionOfAssets1`	$-476.75K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-51.92K	USD	Annual
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$-127.74K	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.10M	USD	Annual
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$1.26M	USD	Annual
Loss on debt extinguishment, net	`GainsLossesOnExtinguishmentOfDebt`	$-266.37K	USD	Annual
Loss on debt extinguishment, net	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Amortization of deferred financing costs	`AdjustmentForAmortization`	$121.58K	USD	Annual
Amortization of deferred financing costs	`AdjustmentForAmortization`	$94.91K	USD	Annual
Write-off of capitalized offering costs	`WriteoffOfCapitalizedOfferingCosts`	-	USD	Annual
Write-off of capitalized offering costs	`WriteoffOfCapitalizedOfferingCosts`	$513.65K	USD	Annual
Amortization of debt discount, net of out of period correction	`AmortizationOfDebtDiscountPremium`	$-29.98K	USD	Annual
Amortization of debt discount, net of out of period correction	`AmortizationOfDebtDiscountPremium`	$400.39K	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$-408.69K	USD	Annual
Change in fair value of warrant and conversion feature liability	`GainLossOnDerivativeInstrumentsNetPretax`	$833.54K	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment of goodwill and intangible assets	`GoodwillAndIntangibleAssetImpairment`	$207.28K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$912.21K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$27.20K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$188.24K	USD	Annual
Other receivables	`IncreaseDecreaseInOtherReceivables`	$-283.70K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-15.89K	USD	Annual
Due from affiliates	`IncreaseDecreaseDueFromAffiliates`	$-55.36K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$118.05K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$92.18K	USD	Annual
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	-	USD	Annual
Deferred financing costs	`IncreaseDecreaseInDeferredCharges`	$43.33K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-3.18K	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$106.51K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$851.28K	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$1.02M	USD	Annual
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	-	USD	Annual
Deferred rent liability	`IncreaseDecreaseInOtherDeferredLiability`	$57.91K	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$249.61K	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$1.41M	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-271.91K	USD	Annual
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-1.84M	USD	Annual
Acquisitions, net of $0 and $660,893 of cash and cash equivalents acquired during the year ended March 31, 2016 and 2015, respectively	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	Annual
Acquisitions, net of $0 and $660,893 of cash and cash equivalents acquired during the year ended March 31, 2016 and 2015, respectively	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.36M	USD	Annual
Proceeds from the sale of ACC assets	`ProceedsFromDivestitureOfBusinesses`	$15.00K	USD	Annual
Proceeds from the sale of ACC assets	`ProceedsFromDivestitureOfBusinesses`	-	USD	Annual
Increase in cash on consolidation of variable interest entity	`CashIncreaseOnConsolidationOfVariableInterestEntity`	$271.39K	USD	Annual
Increase in cash on consolidation of variable interest entity	`CashIncreaseOnConsolidationOfVariableInterestEntity`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$438.88K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$44.51K	USD	Annual
Property and equipment acquired	`PaymentsToAcquirePropertyPlantAndEquipment`	$262.11K	USD	Annual
Increase in restricted cash	`IncreaseInRestrictedCash`	$510.00K	USD	Annual
Increase in restricted cash	`IncreaseInRestrictedCash`	-	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-3.20M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-247.11K	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from issuance of convertible note payable	`ProceedsFromConvertibleDebt`	$2.00M	USD	Annual
Repayments on convertible notes	`RepaymentsOfOtherShortTermDebt`	$470.00K	USD	Annual
Repayments on convertible notes	`RepaymentsOfOtherShortTermDebt`	-	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	-	USD	Annual
Proceeds from notes payable	`ProceedsFromNotesPayable`	$100.00K	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from line of credit	`ProceedsFromLinesOfCredit`	$1.00M	USD	Annual
Repayments on lines of credit	`RepaymentsOfLinesOfCredit`	$1.01M	USD	Annual
Repayments on lines of credit	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$936.08K	USD	Annual
Principal payments on notes payable	`PrincipalPaymentsOnTermNotePayable`	$6.53M	USD	Annual
Contributions by noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	Annual
Contributions by noncontrolling interest	`ProceedsFromMinorityShareholders`	$725.28K	USD	Annual
Distributions to noncontrolling interest	`PaymentsToMinorityShareholders`	$600.00K	USD	Annual
Distributions to noncontrolling interest	`PaymentsToMinorityShareholders`	$702.64K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$533.65K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$200.00K	USD	Annual
Payment to noncontrolling interest for equity interest	`PaymentToNoncontrollingInterestForEquityInterestAmount`	$-500.00	USD	Annual
Payment to noncontrolling interest for equity interest	`PaymentToNoncontrollingInterestForEquityInterestAmount`	$-251.85K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.66M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$6.34M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.82M	USD	Annual
Net change in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.26M	USD	Annual
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$6.83M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$9.27M	USD	Point-in-time
Cash and cash equivalents, end of year	`CashAndCashEquivalentsAtCarryingValue`	$5.01M	USD	Point-in-time
Interest paid	`InterestPaid`	$768.85K	USD	Annual
Interest paid	`InterestPaid`	$521.34K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$176.59K	USD	Annual
Income taxes paid	`IncomeTaxesPaid`	$32.20K	USD	Annual
Convertible note warrant	`ConvertibleNoteWarrant`	$487.62K	USD	Annual
Convertible note warrant	`ConvertibleNoteWarrant`	-	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	-	USD	Annual
Convertible note conversion feature	`DebtInstrumentConvertibleBeneficialConversionFeature`	$578.15K	USD	Annual
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	Annual
Acquisition related warrant consideration	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$132.00K	USD	Annual
Acquisition related consideration fair value of units issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	Annual
Acquisition related consideration fair value of units issued by consolidated subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	Annual
Acquisition related deferred tax liability	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	-	USD	Annual
Acquisition related deferred tax liability	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$218.18K	USD	Annual
Pre-acquisition net equity of noncontrolling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	Annual
Pre-acquisition net equity of noncontrolling interest in variable interest entity	`NoncontrollingInterestIncreaseFromBusinessCombination`	$191.15K	USD	Annual
Issuance of common stock on conversion of 8% warrants and notes	`NoncashOrPartnoncashIssuanceOfCommonStockForExtinguishmentOfDebt`	-	USD	Annual
Issuance of common stock on conversion of 8% warrants and notes	`NoncashOrPartnoncashIssuanceOfCommonStockForExtinguishmentOfDebt`	$3.06M	USD	Annual
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Issuance of common stock in connection with conversion of 9% notes payable and accrued interest	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$553.85K	USD	Annual
Change in non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	$338.03K	USD	Annual
Change in non-controlling interest ownership	`IncreaseDecreaseInNoncontrollingInterestOwnership`	-	USD	Annual
Tenant improvement allowance	`TenantImprovementAllowance`	-	USD	Annual
Tenant improvement allowance	`TenantImprovementAllowance`	$659.36K	USD	Annual
Note receivable related to sale of ACC asset	`NotesReceivableRelatedToSaleOfAssets`	$51.00K	USD	Annual
Note receivable related to sale of ACC asset	`NotesReceivableRelatedToSaleOfAssets`	-	USD	Annual
Convertible debt reclassified to accounts payable	`LiabilitiesAssumed1`	-	USD	Annual
Convertible debt reclassified to accounts payable	`LiabilitiesAssumed1`	$100.00K	USD	Annual
Common stock issued for acquisition of intangible assets	`StockIssued1`	-	USD	Annual
Common stock issued for acquisition of intangible assets	`StockIssued1`	$1.31M	USD	Annual

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.47M	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-1.35M	USD	Annual
Net income (loss)	`ProfitLoss`	$-8.17M	USD	Annual
Issuance of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$132.00K	USD	Annual
Contribution of noncontrolling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$725.28K	USD	Annual
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	Annual
Issuance of membership interest in subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$274.15K	USD	Annual
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.10M	USD	Annual
Stock-based compensation expense	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.26M	USD	Annual
Issuance of common stock in acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.51M	USD	Annual
Distributions to noncontrolling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$600.00K	USD	Annual
Distributions to noncontrolling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$702.64K	USD	Annual
Reclassification of noncontrolling interest to notes receivable	`ReclassificationOfNoncontrollingInterestToNotesReceivable`	$414.72K	USD	Annual
Net adjustment from change in APS ownership interest	`AdjustmentsToAdditionalPaidInCapitalOther`	$-305.31K	USD	Annual
Conversion of 9% notes to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Conversion of 9% notes to common stock	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$553.85K	USD	Annual
Conversion of 8% notes and warrants to common stock	`StockIssuedDuringPeriodValueConversionOfNotesAndWarrants`	$3.06M	USD	Annual
Issuance of preferred stock and equity warrant	`StockIssuedDuringPeriodValueNewIssues`	$5.00M	USD	Annual
Pre-acquisition net equity of noncontrolling interest in variable	`NoncontrollingInterestIncreaseFromBusinessCombination`	-	USD	Annual
Pre-acquisition net equity of noncontrolling interest in variable	`NoncontrollingInterestIncreaseFromBusinessCombination`	$191.15K	USD	Annual
Repurchase of common stock	`StockRepurchasedDuringPeriodValue`	$500.00	USD	Annual
Partial shares paid out in connection with 1 for 10 reverse stock split	`PartialValueOfSharesPaidOutInConnectionWithReverseStockSplit`	-	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-990.18K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.62M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.47M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.